RSV (respiratory syncytial virus) vaccines are a self-paid item in Hong Kong, with no government subsidy.
Products
Hong Kong has two approved adult RSV vaccines:
- Arexvy (manufacturer GSK): for adults aged 60 and over.
- Abrysvo (manufacturer Pfizer): for adults aged 60 and over; it can also be given during pregnancy to protect newborn infants through maternal antibodies.
Both are given as a single dose.
Reference prices
- Per dose (similar for both): about HK$3,000–3,500.
Which one suits you depends on your age, health (or pregnancy) status — discuss it with your family doctor and refer to the Centre for Health Protection and the product information. These are indicative private-market ranges as of June 2026 and vary by clinic. Confirm the current fee and availability with the clinic before you go.